Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Pulmonary Embolism: Role of Catheter-Based Interventions

Baylor College of Medicine

P. Loyalka

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

Is There a Role for Splenectomy in ITP?

Platelet Disorder Support Association (PDSA)

C. Kessler

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

Recent Advances in Classical Hematology

Indy Hematology Review

R. Brodsky

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

Key Insights on the FDA Approval of Marstacimab for Hemophilia

Akshat Jain

ASH 2024 Summary: Overview of Non-Surgical Management of Heavy Menst…

2024 ASH Annual Meeting Insights Hub

A. Wheeler

Natural History of ITP: Navigating the Journey

Platelet Disorder Support Association (PDSA)

D. Kuter

Are All New ITP Treatments Better Than Old Ones: Other Treatments to…

Platelet Disorder Support Association (PDSA)

H. Liebman

ITP: Diagnosis, Pathophysiology, and Management Guidelines

Songphol Tungjitviboonkun

Where Does Rituximab Fit in ITP

Platelet Disorder Support Association (PDSA)

D. Nugent

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia:…

Massachusetts General Hospital Cancer Center

H. Al-Samkari

2024 Benign Hematology Updates

University of Colorado Division of Hematology

L. Chu

Sequencing Treatments in Hemophilia A: When to Switch and Why

Cedric R. Hermans

Causes of Secondary ITP and Long-Term Risk of Other Diseases in ITP …

Platelet Disorder Support Association (PDSA)

D. Kuter